RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Acorda Therapeutics Stock

Acorda Therapeutics Employees 2024

Acorda Therapeutics Employees

344

Ticker

ACOR

ISIN

US00484M6012

WKN

A0BK80

In 2024, Acorda Therapeutics employed 344 people, a 0% change from the 344 number of employees in the previous year.

Acorda Therapeutics Aktienanalyse

What does Acorda Therapeutics do?

Acorda Therapeutics Inc. is a US-based biopharmaceutical company that specializes in researching, developing, and marketing therapeutics for severe neurological diseases. The company was founded in 1995 by Ron Cohen and is headquartered in Ardsley, New York. Acorda Therapeutics started as a small company with few employees and one product, Zanaflex Capsules, a muscle relaxant used for spastic conditions. The company expanded its product portfolio through acquisitions, such as the acquisition of Neuronetrix Solutions, Inc., a company specialized in diagnosing Alzheimer's and other cognitive impairments. Acorda Therapeutics has a business model focused on research and development activities and has formed partnerships with industry experts, academic institutions, and healthcare facilities to support its research efforts. The company has a strong focus on neurology and has expertise in developing protein and antibody-based medications for neurological diseases. Acorda Therapeutics' goal is to meet the needs of patients with severe neurological diseases and develop innovative therapeutics that provide real clinical benefits. The company's main products are Ampyra, an oral medication for improving walking ability in patients with multiple sclerosis, and Zanaflex Capsules, used to treat spastic conditions. Acorda Therapeutics has also developed Inbrija, an inhaled levodopa for treating off-episodes in patients with Parkinson's disease. In addition to medications, the company has developed diagnostic and monitoring devices, such as a device for monitoring vagus nerve stimulation in epilepsy patients, in partnership with Medtronic. Acorda Therapeutics has made significant contributions to the treatment of neurological diseases and has a track record of success in developing collaborative therapies and diagnostic products. While there is still much work to be done, there is hope that continued research and development of new and innovative therapeutics can improve the quality of life for millions of people suffering from severe neurological diseases. Acorda Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Acorda Therapeutics's Employee Base

Acorda Therapeutics's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Acorda Therapeutics's operational capacity and future potential.

Year-to-Year Comparison

Assessing Acorda Therapeutics's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Acorda Therapeutics's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Acorda Therapeutics’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Acorda Therapeutics stock

How many employees does Acorda Therapeutics have this year?

Acorda Therapeutics has 344 undefined employees this year.

How many employees did Acorda Therapeutics have compared to the previous year?

Compared to the previous year, Acorda Therapeutics had 0% more employees.

What impact did the number of employees have on the company Acorda Therapeutics?

The number of employees has a direct impact on the efficiency and productivity of Acorda Therapeutics. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Acorda Therapeutics?

The number of employees can also have an impact on investors of Acorda Therapeutics, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Acorda Therapeutics affect the company?

An increase in equity of Acorda Therapeutics can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Acorda Therapeutics's equity affect the company?

A reduction in equity of Acorda Therapeutics can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Acorda Therapeutics?

Some factors that can influence the equity of Acorda Therapeutics include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Acorda Therapeutics so important for investors?

The equity of Acorda Therapeutics is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Acorda Therapeutics influence the company?

The number of employees at Acorda Therapeutics can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Acorda Therapeutics evolved in recent years?

In recent years, the number of employees at Acorda Therapeutics has changed by 0.

How many employees does Acorda Therapeutics currently have?

Acorda Therapeutics currently has 344 undefined employees.

Why is the number of employees important for investors of Acorda Therapeutics?

The number of employees is important for investors of Acorda Therapeutics as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Acorda Therapeutics take to change the number of employees?

To change the number of employees, Acorda Therapeutics can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Acorda Therapeutics pay?

Over the past 12 months, Acorda Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Acorda Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Acorda Therapeutics?

The current dividend yield of Acorda Therapeutics is .

When does Acorda Therapeutics pay dividends?

Acorda Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Acorda Therapeutics?

Acorda Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Acorda Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Acorda Therapeutics located?

Acorda Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Acorda Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Acorda Therapeutics from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Acorda Therapeutics pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Acorda Therapeutics in the year 2023?

In the year 2023, Acorda Therapeutics distributed 0 USD as dividends.

In which currency does Acorda Therapeutics pay out the dividend?

The dividends of Acorda Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Acorda Therapeutics

Our stock analysis for Acorda Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Acorda Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.